Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sloan

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2019
Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up AnalysisVishal K Gupta, Dina Brauneis, Anthony C Shelton, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
A prospective, single-center, randomized phase 2 trial of etoposide in severe COVID-19Meredith Halpin, Adam Lerner, Manish Sagar, et al.
Haematologica|November 13, 2012
Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trialVaishali Sanchorawala, Jaymin M Patel, J Mark Sloan, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 22, 2015
Clinical presentation and treatment responses in IgM-related AL amyloidosisMoussa Sissoko, Vaishali Sanchorawala, David Seldin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 16, 2011
Macroglossia - not always AL amyloidosisAndrew J Cowan, Martha Skinner, John L Berk, et al.
Transplantation and Cellular Therapy|August 15, 2022
Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain AmyloidosisHamza Hassan, Karina Verma, Grace Ferri, et al.
Cancer Gene Therapy|October 19, 2002
MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsJ Mark Sloan, Michael H Kershaw, Christopher E Touloukian, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 8, 2018
Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patientsAnita Pudusseri, India Smith, Diane Sarnacki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 11, 2015
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical TrialVaishali Sanchorawala, Dina Brauneis, Anthony C Shelton, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|June 19, 2016
Improving the retrieval rate of inferior vena cava filters with a multidisciplinary team approachElica Inagaki, Alik Farber, Mohammad H Eslami, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2019
Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up AnalysisVishal K Gupta, Dina Brauneis, Anthony C Shelton, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
A prospective, single-center, randomized phase 2 trial of etoposide in severe COVID-19Meredith Halpin, Adam Lerner, Manish Sagar, et al.
Haematologica|November 13, 2012
Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trialVaishali Sanchorawala, Jaymin M Patel, J Mark Sloan, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 22, 2015
Clinical presentation and treatment responses in IgM-related AL amyloidosisMoussa Sissoko, Vaishali Sanchorawala, David Seldin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 16, 2011
Macroglossia - not always AL amyloidosisAndrew J Cowan, Martha Skinner, John L Berk, et al.
Transplantation and Cellular Therapy|August 15, 2022
Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain AmyloidosisHamza Hassan, Karina Verma, Grace Ferri, et al.
Cancer Gene Therapy|October 19, 2002
MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsJ Mark Sloan, Michael H Kershaw, Christopher E Touloukian, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 8, 2018
Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patientsAnita Pudusseri, India Smith, Diane Sarnacki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 11, 2015
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical TrialVaishali Sanchorawala, Dina Brauneis, Anthony C Shelton, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|June 19, 2016
Improving the retrieval rate of inferior vena cava filters with a multidisciplinary team approachElica Inagaki, Alik Farber, Mohammad H Eslami, et al.
Pageof 7